retatrutide fda approval status eli lilly Phase 3 obesity trial results 2026 Eli Lilly advances retatrutide, trials

Does that mean that orforglipron could be a viable, tablet-based alternative to Wegovy injections

As new legislation forces the industry to adapt, plan sponsors must seek forward-thinking platforms already aligned with the changes to provide better pricing and care for members

The scale may not move much, but muscle preservation is still occurring

2006 Jul-Aug;29(7):594-8

Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose

Key Pharma Players Shaping the Future The competitive landscape in T2D is crowded with established giants and emerging innovators pushing new approaches